Wave Life Sciences Ltd Suvodirsen Update Conference Call Transcript
Good morning, and welcome to the Wave Life Sciences Investor Conference Call.
(Operator Instructions)
As a reminder, this call is being recorded and webcast. I'll now turn the call over to Kate Rausch, Head of Investor Relations at Wave Life Sciences. Please go ahead.
Thank you, operator. Good morning, and thank you for joining us. With me here today is Dr. Paul Bolno, President and CEO of Wave Life Sciences; and Dr. Panzara, Wave's Chief Medical Officer. This morning, we issued a news release announcing an update on suvodirsen. Please note that this news release is available in the Investors section of our website, www.wavelifesciences.com.
Before we begin, I would like to remind you that discussions during this conference call will include forward-looking statements. These statements are subject to a number of risks and uncertainties that could cause our actual results to differ materially from those described
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |